Maravai Lifesciences Holdings (MRVI) Stock Statistics & Valuation Metrics

Maravai Lifesciences Holdings has a market cap or net worth of $1.61B. The enterprise value is $1.55B.

Maravai Lifesciences Holdings has 147,506,160 shares outstanding. The number of shares has decreased by -2.65% in one year.

Maravai Lifesciences Holdings’s return on equity (ROE) is -0.62 and return on invested capital (ROIC) is -0.91%.

The current PE Ratio of Maravai Lifesciences Holdings is ―. Maravai Lifesciences Holdings’s PEG ratio is 0.27.

In the last 12 months, Maravai Lifesciences Holdings had revenue of 185.74M and earned -130.77M in profits. Earnings per share was -0.91.

In the last 12 months, operating cash flow was -39.52M and capital expenditures -12.35M, giving a free cash flow of -51.87M billion.

Maravai Lifesciences Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

Maravai Lifesciences Holdings upcoming earnings date is Aug 11, 2026, After Close (Confirmed).

Maravai Lifesciences Holdings as a current ratio of 6.60, with Debt / Equity ratio of 128.04%

In the past 12 months, Maravai Lifesciences Holdings has paid -4.21M in taxes.

Maravai Lifesciences Holdings EV to EBITDA ratio is -4.87, with an EV/FCF ratio of -10.13.

Maravai Lifesciences Holdings has $165.92M in cash and marketable securities with $270.88M in debt, giving a net cash position of -$104.96M billion.

Gross margin is 29.00%, with operating margin of -3.63%, and net profit margin of -70.41%.

The average price target for Maravai Lifesciences Holdings is $5.67, which is 11.43% higher than the current price. The consensus rating is Moderate Buy